Delving into the Latest Updates on Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech) with Synapse

Overview

Basic Info

Drug Type

Cell therapy

Synonyms

Target-

Mechanism

Cell replacements

Therapeutic Areas

Nervous System DiseasesSkin and Musculoskeletal Diseases

Active Indication

Arthralgia

Inactive Indication-

Originator Organization

BioTissue Holdings, Inc.

Active Organization

BioTissue Holdings, Inc.

Inactive Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Login to view timeline

This is a pilot study examining the safety and efficacy of a single intra-articular (IA) injection of TTAX03 per joint to relieve severe spinal facet joint (FJ) pain and improve function in subjects with facet joint pain (FJP) in the lumbosacral region. The design is randomized, double blinded, placebo controlled and dose-group sequential.

Start Date15 Jul 2024

Sponsor / Collaborator

BioTissue Holdings, Inc.

100 Clinical Results associated with Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech)

Login to view more data

100 Translational Medicine associated with Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech)

Login to view more data

100 Patents (Medical) associated with Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech)

Login to view more data

100 Deals associated with Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech)

Login to view more data